Pim-1 regulates cardiomyocyte survival downstream of Akt

Nature Medicine

Volumn 13, Issue 12, 2007, Pages 1467-1475

  Muraski, John A ^a   Rota, Marcello ^b   Misao, Yu ^b   Fransioli, Jenna ^a   Cottage, Christopher ^a   Gude, Natalie ^a   Esposito, Grazia ^b   Delucchi, Francesca ^b   Arcarese, Michael ^b   Alvarez, Roberto ^a   Siddiqi, Sailay ^a   Emmanuel, Gregory N ^a   Wu, Weitao ^a   Fischer, Kimberlee ^a   Martindale, Joshua J ^a   Glembotski, Christopher C ^a   Leri, Annarosa ^b   Kajstura, Jan ^b   Magnuson, Nancy ^c   Berns, Anton ^d   Beretta, Remus M ^e   Houser, Steven R ^e   Schaefer, Erik M ^f   Anversa, Piero ^b   Sussman, Mark A ^a   more..

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INVITROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE PIM 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL NUCLEUS; HUMANS; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-PIM-1; RATS;

MUS;

EID: 36849037512     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1671     Document Type: Article

References (50)

1. Wang, Z. et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J. Vet. Sci. 2, 167-179 (2001).
2. Bachmann, M. & Moroy, T. The serine/threonine kinase Pim-1. Int. J. Biochem. Cell Biol. 37, 726-730 (2005).
3. Aho, T.L. et al. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett. 571, 43-49 (2004).
4. Hammerman, P.S., Fox, C.J., Birnbaum, M.J. & Thompson, C.B. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105, 4477-4483 (2005).
5. Pekarsky, Y. et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc. Natl. Acad. Sci. USA 97, 3028-3033 (2000).
6. Shiraishi, I. et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ. Res. 94, 884-891 (2004).
7. Krumenacker, J.S., Narang, V.S., Buckley, D.J. & Buckley, A.R. Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase. J. Neuroimmunol. 113, 249-259 (2001).
8. Krishnan, N., Pan, H., Buckley, D.J. & Buckley, A. Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling. Endocrine 20, 123-130 (2003).
9. Koike, N., Maita, H., Taira, T., Ariga, H. & Iguchi-Ariga, S.M. Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1(1). FEBS Lett. 467, 17-21 (2000).
10. Sussman, M.A. et al. Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice. J. Clin. Invest. 101, 51-61 (1998).
11. Bhattacharya, N. et al. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 111, 80-95 (2002).
12. Camper-Kirby, D. et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res. 88, 1020-1027 (2001).
13. Domen, J., van der Lugt, N.M., Laird, P.W., Saris, C.J. & Berns, A. Analysis of Pim-1 function in mutant mice. Leukemia 7(Suppl. 2), S108-S112 (1993).
14. Konietzko, U. et al. Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP. EMBO J. 18, 3359-3369 (1999).
15. Domen, J. et al. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J. Exp. Med. 178, 1665-1673 (1993).
16. Bullock, A.N., Debreczeni, J., Amos, A., Knapp, S. & Turk, B.E. Structure and substrate specificity of the Pim-1 kinase. J. Biol. Chem. 280, 41675-41682 (2005).
17. Palaty, C.K. et al. Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase. J. Biol. Chem. 272, 10514-10521 (1997).
18. Subramaniam, A. et al. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24613-24620 (1991).
19. Sugden, P.H. & Clerk, A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725-746 (1998).
20. Izumo, S., Nadal-Ginard, B. & Mahdavi, V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA 85, 339-343 (1988).
21. Katakami, N. et al. Role of pim-1 in smooth muscle cell proliferation. J. Biol. Chem. 279, 54742-54749 (2004).
22. Hoefnagel, J.J. et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 105, 3671-3678 (2004).
23. Ionov, Y. et al. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res. 23, 167-178 (2003).
24. Evans, K.E. & Fox, S.W. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 8, 4 (2007).
25. Barre, B., Avril, S. & Coqueret, O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J. Biol. Chem. 278, 2990-2996 (2003).
26. Poolman, R.A., Gilchrist, R. & Brooks, G. Cell cycle profiles and expressions of p21CIP1 and P27KIP1 during myocyte development. Int. J. Cardiol. 67, 133-142 (1998).
27. -/- mice: novel mechanistic insights from in utero ultrasound biomicroscopy. Circ. Res. 95, 92-99 (2004).
28. Torella, D. et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94, 514-524 (2004).
29. Dupays, L. et al. Dysregulation of connexins and inactivation of NFATc1 in the cardiovascular system of Nkx2-5 null mutants. J. Mol. Cell. Cardiol. 38, 787-798 (2005).
30. Lilly, M., Sandholm, J., Cooper, J.J., Koskinen, P.J. & Kraft, A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 18, 4022-4031 (1999).
31. Fujiwara, Y. et al. Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner. Biochem. Biophys. Res. Commun. 340, 560-566 (2006).
32. Wingett, D., Long, A., Kelleher, D. & Magnuson, N.S. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J. Immunol. 156, 549-557 (1996).
33. Rahman, Z., Yoshikawa, H., Nakajima, Y. & Tasaka, K. Down-regulation of Pim-1 and Bcl-2 is accompanied with apoptosis of interleukin-6-depleted mouse B-cell hybridoma 7TD1 cells. Immunol. Lett. 75, 199-208 (2001).
34. Eiken, H.G. et al. Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure. Eur. J. Clin. Invest. 31, 389-397 (2001).
35. Khaleghpour, K., Pyronnet, S., Gingras, A.C. & Sonenberg, N. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol. Cell. Biol. 19, 4302-4310 (1999).
36. Hacker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13 (2006).
37. Zhu, N. et al. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J. Immunol. 168, 744-754 (2002).
38. Krumenacker, J.S. et al. Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine 9, 163-170 (1998).
39. Gude, N. et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ. Res. 99, 381-388 (2006).
40. Tsujita, Y. et al. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA 103, 11946-11951 (2006).
41. Takizawa, T. et al. Transcription of the SERCA2 gene is decreased in pressure-overloaded hearts: A study using in vivo direct gene transfer into living myocardium. J. Mol. Cell. Cardiol. 31, 2167-2174 (1999).
42. 2+ -ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 292, C2269-C2275 (2007).
43. 2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc. Natl. Acad. Sci. USA 101, 9199-9204 (2004).
44. Suarez, J. et al. Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 287, H2164-H2172 (2004).
45. Sakata, S. et al. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J. Mol. Cell. Cardiol. 42, 852-861 (2007).
46. del Monte, F. et al. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc. Natl. Acad. Sci. USA 101, 5622-5627 (2004).
47. Kim, Y.K. et al. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J. Biol. Chem. 278, 47622-47628 (2003).
48. Rota, M. et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ. Res. 97, 1332-1341 (2005).
49. Jacobs, M.D. et al. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002. J. Biol. Chem. 280, 13728-13734 (2005).
50. Kato, T. et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J. Clin. Invest. 115, 2716-2730 (2005).